Evidence map›Paper›PMID 42666927›Full record

ArticleHeart rhythm O22026

Versatility of the novel balloon-in-basket pulsed field ablation catheter: Pulmonary vein isolation and beyond.

Rahin Wahedi, Zeynep Demirtakan, I My, Julia Vogler, Mario Jularic, Jannis Dickow, Tim Harloff, Laura Fischbach, Masih Ruhin, Borislav Dinov and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rahin WahediDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Zeynep DemirtakanDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
I MyDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Julia VoglerDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Mario JularicDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Jannis DickowDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Tim HarloffDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Laura FischbachDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Masih RuhinDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Borislav DinovDepartment for Cardiology and Angiology, University Hospital Marburg and Gießen, Germany.
Samuel SossallaDepartment for Cardiology and Angiology, University Hospital Marburg and Gießen, Germany.
Stephan WillemsDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
Arian SultanDepartment of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulsed field ablation is an established energy source for catheter ablation (CA) of arrhythmias. Recently, a novel balloon-in-basket pulsed field ablation (BiBPFA) catheter has been introduced; however, its use beyond pulmonary vein isolation (PVI) has not yet been studied. Objective: This study aimed to demonstrate the feasibility of versatile CA of atrial fibrillation, atrial flutter (AFL), and atrial tachycardia (AT) using the novel BiBPFA catheter. Methods: Consecutive patients undergoing CA, including index and repeat procedures, using the novel BiBPFA catheter in a single center from June 2025 to March 2026 were analyzed. CA involved PVI/re-PVI, cavotricuspid isthmus ablation, and left atrial substrate modification, including anterior lines, roof lines, posterior wall isolation, and focal ablation. Endpoints included acute procedural success and procedural safety. Results: A total of 42 patients were included (age 68.4 ± 9.7 years; CHA Conclusion: Initial experience with the novel BiBPFA catheter suggests broad procedural versatility beyond PVI, enabling effective mapping and ablation of ATs and right AFL and atrial substrate modification using a single-device approach.

Indexed as

Balloon-in-basket catheterCatheter ablationPulmonary vein isolationPulsed field ablationSingle shot

Identifiers

PMID42666927
PMCPMC13523591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.